1. AB0840 Scleroderma classification criteria: Disease-specific methods for valid case comparisons. (23rd January 2014) Authors: Johnson, S.R.; Naden, R.L.; Fransen, J.; van den Hoogen, F.; Pope, J.E.; Baron, M.; Matucci-Cerinic, M.; Tyndall, A.; Distler, O.; Denton, C.; Gabrielli, A.; van Laar, J.; Mayes, M.; Steen, V.; Seibold, J.; Clements, P.; Medsger, T.; Carreira, P.; Riemekasten, G.; Khanna, D. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 686 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB1162 Looking for minimum standards in care for children with localized scleroderma-result of the consensus meeting in hamburg germany on the 11th of december 2011. Part I. diagnosis and assessment of the disease. (23rd January 2014) Authors: Foeldvari, I.; Constantin, T.; Höger, P.; Nemcova, D.; Pain, C.; Torok, K.; Weibel, L.; Clements, P. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 704 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB1163 Looking for minimum standards in care for children with localized scleroderma-result of the consensus meeting in hamburg germany on the 11th of december 2011. Part II. treatment of juvenile localised scleroderma. (23rd January 2014) Authors: Foeldvari, I.; Constantin, T.; Höger, P.; Nemcova, D.; Pain, C.; Torok, K.; Weibel, L.; Clements, P. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 704 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0252 Efficacy of Mycophenolate Mofetil (MMF) versus Oral Cyclophosphamide (CYC) on Skin Thickness in The Scleroderma Lung Study II. (15th July 2016) Authors: Khanna, D.; Tashkin, D.; Furst, D.E.; Tseng, C.-H.; Wilhalme, H.; Roth, M.; Kafaja, S.; Volkmann, E.; Elashoff, R.; Clements, P. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 525 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0267 Mycophenolate Mofetil versus Oral Cyclophosphamide in Scleroderma-Related Interstitial Lung Disease: Scleroderma Lung Study II. (15th July 2016) Authors: Khanna, D.; Roth, M.; Clements, P.; Furst, D.; Tseng, C.-H.; Elashoff, R.; Volkmann, E.; Kafaja, S.; Goldin, J.; Tashkin, D. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0274 Predictors of Survival in Patients with Systemic Sclerosis-Related Interstitial Lung Disease Enrolled in The Scleroderma Lung Study II. (15th July 2016) Authors: Volkmann, E.; Tashkin, D.; Fischer, A.; Hoffmann-Vold, A.-M.; Tseng, C.-H.; LeClair, H.; Khanna, D.; Clements, P.; Roth, M.; Elashoff, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 534 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0275 Change in CXCL4 Levels May Predict Treatment Response in Systemic Sclerosis-Related Interstitial Lung Disease (SSC-ILD). (15th July 2016) Authors: Volkmann, E.; Tashkin, D.; Elashoff, R.; Tseng, C.-H.; Khanna, D.; Mayes, M.; Charles, J.; Clements, P.; Roth, M.; Furst, D.; Assassi, S. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 535 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0396 Double-blind comparison of mycophenolate mofetil and oral cyclophosphamide for treatment of scleroderma-related interstitial lung disease (scleroderma lung study [SLS] II): rationale, design, methods, baseline characteristics and patient disposition. (23rd January 2014) Authors: Khanna, D.; Roth, M.; Furst, D.; Clements, P.; Goldin, J.; Arriola, E.; Kotlerman, J.; Tseng, C.-H.; Kim, G.; Elashoff, R.; Tashkin, D. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0409 Do we need minimum standards in care for children with localized scleroderma?- result of the consensus meeting in hamburg germany on the 11th of december 2011. part ii. treatment of juvenile localised scleroderma. (23rd January 2014) Authors: Foeldvari, I.; Constantin, T.; Hoeger, P.; Moll, M.; Nemcova, D.; Pain, C.; Torok, K.; Weibel, L.; Clements, P. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OP0213 Systemic Sclerosis is Associated with a Unique Colonic Microbial Consortium. (9th June 2015) Authors: Volkmann, E.; Chang, Y.-L.; Barroso, N.; Furst, D.; Clements, P.; Tong, M.; Roth, B.; Conklin, J.; Getzug, T.; Braun, J. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗